AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This is a Phase I, double-blind, placebo-controlled, randomised within each dose group, single ascending dose study, with the objective to assess the safety, tolerability and pharmacokinetic profile of AZD8529 in healthy Japanese subjects.
Epistemonikos ID: 6d0564dd809f612ec22540bb3db0b61e102374bd
First added on: May 05, 2024